{"log_id": 8520330677930289941, "direction": 0, "words_result_num": 31, "words_result": [{"probability": {"variance": 0.000208, "average": 0.988132, "min": 0.946894}, "location": {"width": 470, "top": 232, "height": 33, "left": 218}, "words": "Cmax分别为77.7(8.1)和116.6(12.2)μg/m"}, {"probability": {"variance": 1e-06, "average": 0.998377, "min": 0.997301}, "location": {"width": 48, "top": 278, "height": 24, "left": 264}, "words": "分布"}, {"probability": {"variance": 7e-06, "average": 0.998526, "min": 0.985309}, "location": {"width": 740, "top": 321, "height": 37, "left": 263}, "words": "达托霉素可与人血浆蛋白(主要是血清白蛋白)可逆性结合,并且与血药浓"}, {"probability": {"variance": 0.002946, "average": 0.981265, "min": 0.790184}, "location": {"width": 431, "top": 366, "height": 30, "left": 217}, "words": "度不相关。总平均蛋白结合率范围为90-93%"}, {"probability": {"variance": 0.000464, "average": 0.990055, "min": 0.891225}, "location": {"width": 741, "top": 411, "height": 35, "left": 261}, "words": "在临床研究中,肌酐清除率(CL)≥30mL/min的受试者中的平均血清蛋白"}, {"probability": {"variance": 0.009351, "average": 0.96337, "min": 0.473562}, "location": {"width": 786, "top": 454, "height": 39, "left": 215}, "words": "结合率与肾功能正常的健康受试者中的所见相似。然而,在CL<30mL/m的受"}, {"probability": {"variance": 0.000578, "average": 0.993395, "min": 0.843288}, "location": {"width": 786, "top": 498, "height": 39, "left": 215}, "words": "试者中,包括那些接受血液透析(86%)和CAPD(84%)的受试者,其血清蛋白结合"}, {"probability": {"variance": 0.004079, "average": 0.969346, "min": 0.725188}, "location": {"width": 786, "top": 543, "height": 37, "left": 214}, "words": "率有降低的趋势(88%)。达托霉素在中度肝功能不全受试者(Cd- Pugh B级)中"}, {"probability": {"variance": 0.000202, "average": 0.993486, "min": 0.946451}, "location": {"width": 367, "top": 588, "height": 30, "left": 212}, "words": "的蛋白结合率与健康成人受试者相似"}, {"probability": {"variance": 0.002867, "average": 0.978791, "min": 0.751996}, "location": {"width": 743, "top": 631, "height": 40, "left": 257}, "words": "在健康成人受试者中,达托霉素的稳态分布容积(Vss)约为0.1L/kg,并且"}, {"probability": {"variance": 1e-06, "average": 0.999266, "min": 0.99681}, "location": {"width": 182, "top": 679, "height": 27, "left": 216}, "words": "与用药剂量不相关"}, {"probability": {"variance": 0, "average": 0.999838, "min": 0.999786}, "location": {"width": 50, "top": 723, "height": 26, "left": 255}, "words": "代谢"}, {"probability": {"variance": 2.3e-05, "average": 0.997049, "min": 0.978718}, "location": {"width": 523, "top": 765, "height": 37, "left": 256}, "words": "在体外研究中,达托霉素并不被人肝脏微粒体所代谢"}, {"probability": {"variance": 0.000245, "average": 0.995053, "min": 0.909735}, "location": {"width": 744, "top": 810, "height": 38, "left": 255}, "words": "5名健康的青年成人输注放射标记的C达托霉素后,血浆总放射性与微生物"}, {"probability": {"variance": 7e-06, "average": 0.998242, "min": 0.989184}, "location": {"width": 790, "top": 853, "height": 38, "left": 208}, "words": "法所测定的浓度相似。如同测定总放射性浓度和微生物学活性浓度之间差异,尿"}, {"probability": {"variance": 7.2e-05, "average": 0.997081, "min": 0.962151}, "location": {"width": 790, "top": 896, "height": 42, "left": 209}, "words": "液中检测到了无活性代谢产物。在一项单独的研究中,给予受试者6mg/kg本品"}, {"probability": {"variance": 9.3e-05, "average": 0.996934, "min": 0.947465}, "location": {"width": 785, "top": 943, "height": 38, "left": 208}, "words": "后,第1天时在血浆中未观察到代谢产物。在尿液中检测到3种微量的氧化代谢产"}, {"probability": {"variance": 1e-06, "average": 0.999193, "min": 0.996834}, "location": {"width": 568, "top": 989, "height": 35, "left": 209}, "words": "物和一种未鉴定的化合物。达托霉素的代谢部位尚未确定"}, {"probability": {"variance": 0.007374, "average": 0.873717, "min": 0.79772}, "location": {"width": 133, "top": 959, "height": 67, "left": 929}, "words": "四信海"}, {"probability": {"variance": 1e-06, "average": 0.998302, "min": 0.997385}, "location": {"width": 47, "top": 1034, "height": 26, "left": 254}, "words": "排泄"}, {"probability": {"variance": 2.9e-05, "average": 0.997281, "min": 0.977734}, "location": {"width": 747, "top": 1077, "height": 38, "left": 252}, "words": "达托霉素主要经肾脏排泄。在物料平衡研究中,给予5名健康受试者放射标"}, {"probability": {"variance": 0.009792, "average": 0.965966, "min": 0.562501}, "location": {"width": 879, "top": 1116, "height": 49, "left": 204}, "words": "记的达托霉素。根据总放射性,从尿液中回收了大约78%的给药剂量(根据微生物1"}, {"probability": {"variance": 0.002379, "average": 0.984387, "min": 0.742334}, "location": {"width": 789, "top": 1169, "height": 31, "left": 205}, "words": "活性浓度,大约回收52%的给药剂量);而根据总放射性从粪便中回收了5.7%的给"}, {"probability": {"variance": 4.8e-05, "average": 0.99444, "min": 0.981616}, "location": {"width": 190, "top": 1214, "height": 27, "left": 206}, "words": "药剂量(收集达9天"}, {"probability": {"variance": 0.000304, "average": 0.989121, "min": 0.958993}, "location": {"width": 93, "top": 1258, "height": 27, "left": 251}, "words": "特殊人群"}, {"probability": {"variance": 1e-05, "average": 0.998027, "min": 0.99067}, "location": {"width": 164, "top": 1304, "height": 27, "left": 251}, "words": "肾功能损害患者"}, {"probability": {"variance": 0.003393, "average": 0.973272, "min": 0.785975}, "location": {"width": 747, "top": 1344, "height": 39, "left": 249}, "words": "对不同程度肾功能的感染患者(复杂性皮肤及皮肤结构感染[cSSI]和金黄"}, {"probability": {"variance": 0.000138, "average": 0.994897, "min": 0.94885}, "location": {"width": 761, "top": 1390, "height": 36, "left": 205}, "words": "色葡萄球菌菌血症)和非感染受试者人群的药代动力学参数进行了测定(表15"}, {"probability": {"variance": 0.001168, "average": 0.988519, "min": 0.804419}, "location": {"width": 770, "top": 1434, "height": 38, "left": 203}, "words": "患有金黄色葡萄球菌菌血症的患者与 JCSSSI患者具有相似的总血浆清除率(CL)"}, {"probability": {"variance": 0.013155, "average": 0.959364, "min": 0.419116}, "location": {"width": 773, "top": 1479, "height": 41, "left": 201}, "words": "消除半衰期(t2)和稳态分布容积(Vs).30分钟静脉给予本品4mg/kgq24h后"}, {"probability": {"variance": 0.012706, "average": 0.946951, "min": 0.477289}, "location": {"width": 793, "top": 1524, "height": 38, "left": 203}, "words": "对于患有轻度(CLc50~80ml/min)、中度(CLc30~50ml/min)和严重(CLck<30"}], "language": 3}